These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22848619)

  • 21. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison Between Salvage Liver Transplantation and Repeat Liver Resection for Recurrent Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Kostakis ID; Machairas N; Prodromidou A; Stamopoulos P; Garoufalia Z; Fouzas I; Sotiropoulos GC
    Transplant Proc; 2019 Mar; 51(2):433-436. PubMed ID: 30879559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time interval to recurrence as a predictor of overall survival in salvage liver transplantation for patients with hepatocellular carcinoma associated with hepatitis B virus.
    Hu Z; Zhou J; Li Z; Xiang J; Qian Z; Wu J; Zhang M; Zheng S
    Surgery; 2015 Feb; 157(2):239-48. PubMed ID: 25616940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic review of treatment strategy for recurrent hepatocellular carcinoma: Salvage liver transplantation or curative locoregional therapy.
    Wang HL; Mo DC; Zhong JH; Ma L; Wu FX; Xiang BD; Li LQ
    Medicine (Baltimore); 2019 Feb; 98(8):e14498. PubMed ID: 30813151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors in patients with recurrent hepatocellular carcinoma treated with salvage liver transplantation: a single-center study.
    Wang P; Li H; Shi B; Que W; Wang C; Fan J; Peng Z; Zhong L
    Oncotarget; 2016 Jun; 7(23):35071-83. PubMed ID: 27145461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of multiple liver resections prior to salvage liver transplantation on survival in patients with recurrent HCC.
    Hu Z; Zhang Q; Zhou J; Li Z; Xiang J; Zhou L; Wu J; Zhang M; Zheng S
    BMJ Open; 2015 Sep; 5(9):e008429. PubMed ID: 26353871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical efficacy and prognostic risk factors of salvage liver transplantation, rehepatectomy, and local ablation in the treatment of postoperative recurrence of hepatocellular carcinoma].
    Lin P; You YK; Liu JY; Yang F; Cai QC; Jiang Y; Shen JJ
    Zhonghua Gan Zang Bing Za Zhi; 2023 Feb; 31(2):155-160. PubMed ID: 37137830
    [No Abstract]   [Full Text] [Related]  

  • 28. MTM-HCC at Previous Liver Resection as a Predictor of Overall Survival in Salvage Liver Transplantation.
    Yang Y; Sun JH; Tan XY; Lu CD; Huang ZP; Zhu HD; Shi XT; Chen JX; Fang JZ
    Dig Dis Sci; 2023 Jun; 68(6):2768-2777. PubMed ID: 36790686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of salvage liver transplantation.
    Guerrini GP; Gerunda GE; Montalti R; Ballarin R; Cautero N; De Ruvo N; Spaggiari M; Di Benedetto F
    Liver Int; 2014 Jul; 34(6):e96-e104. PubMed ID: 24517642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orthotopic liver transplantation as a rescue operation for recurrent hepatocellular carcinoma after partial hepatectomy.
    Shao Z; Lopez R; Shen B; Yang GS
    World J Gastroenterol; 2008 Jul; 14(27):4370-6. PubMed ID: 18666328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage Liver Transplant versus Primary Liver Transplant for Patients with Hepatocellular Carcinoma.
    Yadav DK; Chen W; Bai X; Singh A; Li G; Ma T; Yu X; Xiao Z; Huang B; Liang T
    Ann Transplant; 2018 Aug; 23():524-545. PubMed ID: 30072683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver Transplantation for High Risk Hepatocellular Carcinoma After Liver Resection: A Sequential or Salvage Approach?
    Lin CC; Elsarawy AM; Li WF; Lin TL; Yong CC; Wang SH; Wang CC; Kuo FY; Cheng YF; Chen CL
    Ann Transplant; 2017 Oct; 22():602-610. PubMed ID: 28993607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short- and long-term outcomes after salvage liver transplantation versus primary liver transplantation for hepatocellular carcinoma: a meta-analysis.
    Zhu Y; Dong J; Wang WL; Li MX; Lu Y
    Transplant Proc; 2013 Nov; 45(9):3329-42. PubMed ID: 24182812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survival comparison between primary transplant and upfront curative treatment with salvage transplant for early stage hepatocellular carcinoma.
    Ng KKC; Cheung TT; Wong TCL; Fung JYY; Dai JWC; Ma KW; She WH; Lo CM
    Asian J Surg; 2019 Feb; 42(2):433-442. PubMed ID: 30262437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond graft function impairment after liver transplantation: the prolonged cold ischemia time impact on recurrence of hepatocellular carcinoma after liver transplantation-a single-center retrospective study.
    Yu J; Yunhua T; Guo Y; Dong Y; Gong JL; Wang T; Chen Z; Chen M; Ju W; He X
    PeerJ; 2024; 12():e18126. PubMed ID: 39376229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
    Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single-center retrospective analysis of liver transplantation on 255 patients with hepatocellular carcinoma.
    Wang ZX; Song SH; Teng F; Wang GH; Guo WY; Shi XM; Ma J; Wu YM; Ding GS; Fu ZR
    Clin Transplant; 2010; 24(6):752-7. PubMed ID: 20030683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival according to recurrence patterns after resection for transplantable hepatocellular carcinoma in HBV endemic area: Appraisal of liver transplantation strategy.
    Seo CG; Yim SY; Um SH; Lee YR; Lee YJ; Kim TH; Goh HG; Lee YS; Suh SJ; Han NY; Choi HS; Kim ES; Keum B; Seo YS; Yim HJ; Kim JH; Kim DS; Jeen YT; Chun HJ; Lee HS; Kim CD
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):532-542. PubMed ID: 31870653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harm and Benefits of Salvage Transplantation for Hepatocellular Carcinoma: An Updated Meta-analysis.
    Xiong Q; Geng TT; He L; Gao H
    Transplant Proc; 2016 Dec; 48(10):3336-3347. PubMed ID: 27931579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing Paradigm in the Surgical Management of Hepatocellular Carcinoma With Salvage Transplantation.
    Ma KW; Chan ACY; She BWH; Chok KSH; Cheung TT; Dai JWC; Fung JYY; Lo CM
    Transplant Proc; 2018 May; 50(4):1087-1093. PubMed ID: 29731072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.